RESUMEN
Infantile colic (IC) is c is a self-limiting functional gastrointestinal disorder (FGID) with a favorable natural history. Worldwide, IC has a significant impact on many newborns and their families. Although not an indication of an illness, its symptoms are wide and generic and may indicate a potentially serious underlying issue in a tiny percentage of newborns who may require a medical evaluation. The pathogenesis appears to be multifactorial implying a complex relationship between the infant and the environment. One of the most studied theories attributes a key role to the gut microbiota in the pathogenesis of IC. A variety of approaches have been suggested for the clinical management of IC, and several randomized controlled trials have been reported in the literature. Probiotics can change the host's microbiota and positively impact health. They may be able to restore balance and create a better intestinal microbiota landscape since there is mounting evidence that the gut microbial environment of colicky newborns differs from that of healthy infants. In this review, we revise the most commonly studied probiotics and mixtures to treat and prevent IC and the most recent recommendations.
Asunto(s)
Cólico , Microbioma Gastrointestinal , Probióticos , Humanos , Cólico/terapia , Cólico/prevención & control , Cólico/microbiología , Probióticos/uso terapéutico , Recién Nacido , LactanteRESUMEN
Recent metanalysis reported that certain probiotic strains, such as Limosilactobacillus reuteri and Lacticaseibacillus rhamnosus (LGG), seem effective for treatment of infantile colic of exclusively breastfed infants; some reports have also linked probiotics to have an immunological effect, however further investigation are needed to fully understand the exact mechanism. The objective of this study was to assay white blood cells, tumour necrosis factor (TNF)-α and interleukin (IL)-6 values in peripheral blood in subjects treated in a randomised, double-blind, placebo-controlled trial for infantile colic with LGG. Fifty-eight infants were enrolled and followed for a study period of 28 days. Parent were asked to record daily crying time using a structured cry diary. Peripheral white blood cells was assessed and RNA (mRNA) expression of TNF-α and IL-6 was measured using TaqMan real-time PCR-maternal amplification. Infants with colic treated with LGG showed a reduction in daily crying duration after 28 days of treatment and a reduction in values of IL-6 ( P < 0.005) and TNF-α ( P < 0.05); we observe also a significantly decreasing of IL-6 in the placebo group while decrease of TNF-α was not significant in this group. A significant decreased values of monocytes ( P < 0.05) was observed in infants treated with LGG. Our data therefore showed, in addition to crying time reduction, a significant decrease of TNF-α and a significant reduction of monocytes cells in colicky infants treated with LGG, compared to placebo group. This observation supports the hypothesis that probiotics may have anti-inflammatory properties. Further studies are needed to better understand the influence of probiotic on immunity cells.
Asunto(s)
Cólico , Interleucina-6 , Lacticaseibacillus rhamnosus , Leucocitos , Probióticos , Factor de Necrosis Tumoral alfa , Humanos , Cólico/terapia , Probióticos/administración & dosificación , Probióticos/uso terapéutico , Interleucina-6/sangre , Interleucina-6/genética , Factor de Necrosis Tumoral alfa/sangre , Femenino , Método Doble Ciego , Lactante , Masculino , Estudios Prospectivos , Leucocitos/inmunología , Llanto , Resultado del TratamientoRESUMEN
Functional gastrointestinal disorders (FGID), such as infant regurgitation, infant colic, and functional constipation, are common and typically physiological phenomena during the early months of an infant's life and account for frequent consultations with pediatricians. Various infant formulas are marketed for their management and are frequently given by parents to infants before a medical consultation. However, the evidence supporting their effectiveness is limited and some have altered nutritional compositions when compared to standard formulas. Thus, these products should only be used under medical supervision and upon medical advice. Marketing and over-the-counter sales do not ensure proper medical guidance and supervision. The aim of this position paper is to review the current evidence regarding the safety and efficacy of formulas specifically formulated for addressing regurgitation, colic, and constipation, recognized as FGID. The objective is to provide guidance for clinical management based on the highest quality of available evidence. A wide search using Pubmed, MEDLINE, EMBASE and Cochrane Database of Systematic Reviews was performed including the MESH terms infant formula, colic, constipation, regurgitation, reflux, palmitate, lactase, lactose, magnesium, hydrolyzed protein, prebiotics or probiotics. 752 papers were identified and screened. Finally, 72 papers were included in the paper. In the absence of evidence, recommendations reflect the authors' combined expert opinion. Final consensus was obtained by multiple e-mail exchange and meetings of the Nutrition Committee. (1) For breastfed infants experiencing FGID such as regurgitation, colic, or constipation, transitioning from breastfeeding to commercial formulas is not recommended. (2) In general, whether an infant is breastfed or formula-fed, it's crucial to reassure parents that FGIDs are normal and typically do not necessitate treatment or change to a special formula. (3) Thickened formulas, often termed anti-reflux formulas, may be considered in specific cases of regurgitation. (4) The usage of specialized formulas for infants with colic is not advised due to a lack of clinical evidence. (5) In the case of constipation in infants, the use of formulas enriched with high ß-palmitate and increased magnesium content may be considered to soften the stool. Generally, there is limited evidence supporting the use of specialized formulas for FGID. Breastfeeding should never be discontinued in favor of formula feeding.
Asunto(s)
Enfermedades Gastrointestinales , Fórmulas Infantiles , Humanos , Lactante , Enfermedades Gastrointestinales/terapia , Recién Nacido , Estreñimiento/terapia , Cólico/terapiaRESUMEN
Infantile functional gastrointestinal disorders, such as colic, constipation, diarrhea, and gastroesophageal reflux (regurgitation), often occur in early infancy and, representing one of the causes of significant parental anxiety, lead to a significant strain on the healthcare resources. In this study, we aimed to evaluate the effects of Lactobacillus reuteri drops (L. reuteri NCIMB 30351) on the symptoms of infantile colic, constipation, diarrhea, and gastroesophageal reflux, as well as on the levels of intestinal microbiota in full-term newborns during the first months of life. A randomized, placebo-controlled, single-masked (blinded), post-marketing clinical study was conducted in two clinical units-Children's City Clinical Hospital of Moscow and Medical Center "St. Andrew's Hospitals-NEBOLIT" from March 2020 to May 2022 in 90 infants aged from 1 to 4 months (mean age (± SD) 12.3 ± 5.09 weeks; 53.3% females, 46.7% males). Patients with colic, regurgitation (single symptom or combination of several symptoms), and constipation or diarrhea were randomly allocated in two parallel arms to receive either 5 drops (2 × 108 colony forming unit) of L. reuteri NCIMB 30351 (n = 60) or masked placebo (n = 30) for 25 consecutive days. Two treatment arms had equal numbers of patients with constipation and diarrhea (n = 30 each). Daily crying times and their duration, evacuations, and regurgitations were recorded in a structured diary. The levels of gut microbiota were analyzed by deep sequencing of bacterial 16S rRNA gene. Infants with colic receiving supplementary L. reuteri NCIMB 30351 for 25 days had significant reduction in the numbers of colic (change from baseline - 6.3 (7.34) vs - 3.0 (7.29) in placebo, P < 0.05) and numbers of crying cases and mean duration of crying (decrease from baseline - 144 (70.7) minutes, lower in the diarrhea subgroup than in constipation infants, compared with - 80 (58.9) in placebo, P < 0.0001), as well as regurgitation numbers (decreased by - 4.8 (2.49) with L. reuteri vs - 3 (7.74) with placebo). We also observed increased numbers of evacuations in infants with constipation (L. reuteri 2.2 (2.4) vs 0.9 (1.06) in placebo, P < 0.05). There was a remarkable reduction of evacuations in infants with diarrhea, while not statistically significant. The analysis of bacterial 16S rRNA gene in the collected samples showed that L. reuteri positively influences the proportions of prevalent species, while it negatively affects both conditionally pathogenic and commensal microbes. Additional in vitro test for formation of Clostridium colonies in the presence of the probiotic demonstrated that L. reuteri effectively inhibits the growth of pathogenic Clostridium species. No adverse events were reported in this study. Conclusion: The uptake of L. reuteri NCIMB 30351 leads to a significant reduction in the number of regurgitations, feeding-induced constipations, and diarrhea as well as mean daily numbers of crying and crying duration in infants during the first months of life. Our results suggest that L. reuteri NCIMB 30351 represents a safe and effective treatment for colic in newborns. Trial registration: ClinicalTrials.gov : NCT04262648. What is Known: ⢠Infantile functional gastrointestinal disorders, such as colic, constipation, diarrhea, and gastroesophageal reflux (regurgitation), often occur in early infancy and, represent one of the causes of significant parental anxiety. ⢠A number of studies have shown that both the composition and diversity of the intestinal microbiota play important roles in the development and function of the gastrointestinal tract. What is New: ⢠The uptake of L. reuteri NCIMB 30351 leads to a significant reduction in the number of regurgitations, feeding-induced constipations, and diarrhea as well as mean daily numbers of crying and crying duration in infants during the first months of life. ⢠L. reuteri positively influences the proportions of prevalent species, while it negatively affects both conditionally pathogenic and commensal microbes in gut microbiota.
Asunto(s)
Enfermedades Gastrointestinales , Microbioma Gastrointestinal , Limosilactobacillus reuteri , Probióticos , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Cólico/terapia , Cólico/microbiología , Estreñimiento/terapia , Estreñimiento/microbiología , Diarrea/microbiología , Diarrea/terapia , Reflujo Gastroesofágico/microbiología , Reflujo Gastroesofágico/terapia , Enfermedades Gastrointestinales/microbiología , Enfermedades Gastrointestinales/terapia , Probióticos/uso terapéutico , Probióticos/administración & dosificación , Método Simple Ciego , Resultado del Tratamiento , Estudios ProspectivosRESUMEN
Different nutraceuticals are often considered by parents of infants and children with abdominal pain and disorders of the gut-brain interaction. Herb extracts and natural compounds have long been used in traditional medicine, but clinical pediatric trials are very limited. This narrative review based on relevant studies identified through a search of the literature in Pubmed and Medline updated to October 2023 focused on the effect of nutraceuticals in infantile colic, functional abdominal pain, and irritable bowel syndrome in children and adolescents. Significant reductions in colic episodes and crying time were reported in two studies on fennel (seeds oil or tea), in three studies on different multiple herbal extracts (all including fennel), in one study on Mentha piperita, and in at least two double-blind randomized controlled studies on Lactobacillus reuteri DSM 17938 and Bifidobacterium lactis BB-12 (108 CFU/day for at least 21 days) in breast-fed infants. Compared to a placebo, in children with functional abdominal pain or irritable bowel syndrome, a significant reduction in pain was reported in two studies supplementing peppermint oil capsules or psyllium fibers, and in one study on corn fiber cookies, partial hydrolyzed guar gum, a specific multiple herbal extract (STW-5), or vitamin D supplementation. To date, there is moderate-certainty evidence with a weak grade of recommendation on Lactobacillus reuteri DSM 17938 (108 CFU/day) in reducing pain intensity in children with functional abdominal pain and for Lactobacillus rhamnosus GG (1-3 × 109 CFU twice daily) in reducing pain frequency and intensity in children with IBS. Further large and well-designed pediatric studies are needed to prove the efficacy and safety of different herbal extracts and prolonged use of studied products in infants and children with pain disorders of the gut-brain interaction.
Asunto(s)
Bifidobacterium animalis , Cólico , Síndrome del Colon Irritable , Limosilactobacillus reuteri , Probióticos , Lactante , Adolescente , Humanos , Niño , Probióticos/uso terapéutico , Dolor Abdominal , Cólico/terapia , Cólico/microbiología , Suplementos Dietéticos , Encéfalo , Resultado del Tratamiento , Ensayos Clínicos Controlados Aleatorios como AsuntoRESUMEN
AIM: This study is a systematic review and meta-analysis of randomised controlled trials that employed probiotics and symbiotics for treating infantile colic. METHODS: We performed electronic systematic literature searches in Embase, PubMed and Web of Science, to identify articles published between 1950 and April 2023. Only RCT involving infants with infantile colic under 3 months were included. The treatment plan comprised 15 probiotics, which included Lactobacillus reuteri DSM 17938 and Bifidobacterium animalis lactis BB-12. The probiotics were administered alone or in combination with a prebiotic, vs. no intervention or a placebo. RESULTS: Probiotics resulted in an average reduction of 51 min of crying per day (p = 0.001). Further analysis of subgroups showed that the reduction was -39.30 min for vaginal delivery (p = 0.003), -64.66 min for Lactobacillus reuteri DSM 17938 (p = 0.03), -40.45 min for other strains (p < 0.00001), -74.28 min for exclusively breastfed infants (p = 0.0003) and -48.04 min for mixed feeding (p < 0.00001). CONCLUSION: All probiotic strains seem effective in treating infantile colic. Exclusively breastfed infants have demonstrated more significant reduction in crying time. However, the available evidence on the effectiveness of probiotics in formula-fed and caesarean-born infants is limited.
Asunto(s)
Cólico , Limosilactobacillus reuteri , Probióticos , Lactante , Embarazo , Femenino , Humanos , Cólico/terapia , Lactancia Materna , Probióticos/uso terapéutico , Emociones , PrebióticosRESUMEN
BACKGROUND: YouTube is increasingly used by patients and parents as a source of information in the field of health. The aim of the study was to measure the quality and reliability levels of the videos published in English on infantile colic (IC) uploaded on YouTube. METHODS: A YouTube search was achieved by two authors using the key words "infantile colic," "baby", "colic", "children" and "treatment". Along with the general features of the videos, their quality and reliability were evaluated according to the global quality score (GQS), modified DISCERN (mDISCERN) score. RESULTS: Among the 55 videos included in the study, 25 (55.6%) were high quality, 19 (42.2%) medium quality and 11 (2.2%) low quality. The mDISCERN and GQS scores of the videos in the useful group were higher than those in the misleading group (p < 0.001). Videos uploaded by academic institutes and physicians had higher mDISCERN and GQS scores than other groups (p = 0.045, p = 0.005) and positive correlation detected between mDISCERN and GQS scores (p < 0.001). CONCLUSION: IC videos broadcasted on YouTube, whose usage rates are increasing with the COVID-19 pandemic, are a useful data source for patients/parents. Digital video resources provided by academic institutions, universities and healthcare professionals can assist physicians and parents in IC pathophysiology and treatment.
Asunto(s)
Cólico , Medios de Comunicación Sociales , Humanos , Cólico/terapia , Fuentes de Información , Pandemias , Reproducibilidad de los ResultadosRESUMEN
The list of medical causes of acute or chronic colic in horses is extensive. The purpose of this article is to review 4 medical causes of equine colic with a focus on newer trends in treatment. The 4 topics selected include gastric impaction, gastric glandular disease, colon displacement, and inflammatory bowel disease.
Asunto(s)
Cólico , Enfermedades de los Caballos , Animales , Caballos , Cólico/terapia , Cólico/veterinaria , Enfermedades de los Caballos/terapia , Enfermedades de los Caballos/etiologíaRESUMEN
Colic is a common presenting complaint in foals. Unfortunately, evaluation of foals with colic can be difficult due to the common clinical presentation of acute abdominal pain attributable to a wide variety of disorders and a broad range of etiologies. Similar to foals, colic is one of the most common diseases of pregnant and periparturient mares. Several conditions are unique or occur more commonly in broodmares. This article reviews the most commonly encountered types of colic events in neonatal foals and periparturient mares, how to correctly diagnose these conditions, as well as details concerning appropriate medical management and/or surgical intervention.
Asunto(s)
Cólico , Enfermedades de los Caballos , Embarazo , Animales , Caballos , Femenino , Cólico/diagnóstico , Cólico/terapia , Cólico/veterinaria , Enfermedades de los Caballos/diagnóstico , Enfermedades de los Caballos/terapia , Enfermedades de los Caballos/etiologíaRESUMEN
Most recurrent episodes of non-specific colic are self-limiting, and the results of clinical examinations are unremarkable. Differentiating these cases from serious diseases can be difficult, but repeated evaluations are warranted. Horses presenting with very frequent bouts of colic are more likely to have serious diseases and a higher mortality rate compared to horses presenting with less frequent bouts of transient colic. Horses with recurrent bouts of prolonged colic are more likely to have motility issues or partial intestinal obstruction. Non-gastrointestinal diseases can also cause recurrent bouts of pain ("false colic"). Adhesions are common causes of colic following abdominal surgery.
Asunto(s)
Cólico , Enfermedades de los Caballos , Obstrucción Intestinal , Animales , Caballos , Motivación , Enfermedades de los Caballos/diagnóstico , Enfermedades de los Caballos/terapia , Enfermedades de los Caballos/etiología , Obstrucción Intestinal/diagnóstico , Obstrucción Intestinal/etiología , Obstrucción Intestinal/terapia , Obstrucción Intestinal/veterinaria , Cólico/diagnóstico , Cólico/terapia , Cólico/veterinariaRESUMEN
Gastrointestinal colic is the most common primary care equine emergency and affects nearly one of four horses per year. Colic is a significant welfare concern for equine patients and a financial and emotional burden for owners. The primary care practitioner is instrumental in identifying critical cases quickly and making appropriate management recommendations to improve patient outcomes.
Asunto(s)
Cólico , Servicios Médicos de Urgencia , Enfermedades de los Caballos , Animales , Caballos , Cólico/diagnóstico , Cólico/terapia , Cólico/veterinaria , Enfermedades de los Caballos/diagnóstico , Enfermedades de los Caballos/terapia , Derivación y ConsultaRESUMEN
OBJECTIVES: In this study, we investigated the relationship between infantile colic, migraine, and biorhythm regulation, by evaluating biochemical and molecular parameters. STUDY DESIGN: Healthy infants with and without infantile colic were eligible for this prospective cohort study. A questionnaire was applied. Between the 6th and 8th postnatal weeks, day and night circadian histone gene H3f3b mRNA expression and spot urine excretion of serotonin, cortisol, and 6-sulphatoxymelatonin were analyzed. RESULTS: Among the 95 infants included, 49 were diagnosed with infantile colic. In the colic group, defecation difficulty, sensitivity to light/sound, and maternal migraine frequency increased and sleep disruption was typical. In the melatonin analysis, the difference between day and night levels was significant in the control group, indicating an established circadian rhythm ( P = 0.014). In the colic group, there was no day-night difference ( P = 0.216) in melatonin, but serotonin levels were higher at night. In the cortisol analysis, day-night values were similar in both groups. Day-night variability of H3f3b mRNA levels between the groups was significant, indicating circadian rhythm disturbance in the colic group compared to the control group ( P = 0.003). Fluctuations in circadian genes and hormones expected in healthy rhythm were revealed in the control group, but were missing in the colic group. CONCLUSION: Due to the gaps in the etipathogenesis in infantile colic, a unique effective agent has not been discovered so far. This study, which demonstrated for the first time that infantile colic is a biorhythm disorder using molecular methods, fills the gap in this regard and points to a completely different perspective in terms of treatment.
Asunto(s)
Cólico , Melatonina , Trastornos Migrañosos , Lactante , Humanos , Cólico/etiología , Cólico/terapia , Melatonina/fisiología , Estudios Prospectivos , Hidrocortisona , Serotonina , Ritmo Circadiano/fisiologíaRESUMEN
AIM: Osteopathy and chiropractic techniques are used for babies for different reasons, but it is unclear how effective they are. The aim of this study was to evaluate their effectiveness in reducing crying time and increasing sleeping time in babies with infantile colic. METHODS: A systematic review and meta-analysis was conducted on infantile colic studies that used complementary and alternative medicine techniques as interventions. The outcome measures were hours spent crying and/or sleeping. We used the PubMed, Physiotherapy Evidence Database, Cochrane Library, Embase, Web of Science, Scopus, Osteopathic Medicine Digital Database and Google Scholar databases from inception to 11 November 2022. RESULTS: The methodological quality of the randomised control trials ranged from fair to high. We focused on five studies with 422 babies. Complementary treatments failed to decrease the crying time (mean difference -1.08, 95% CI: -2.17 to 0.01, I2 = 92%) and to increase sleeping time (mean difference 1.11, 95% CI: -0.20 to 2.41; I2 : 91%), compared with no intervention. The quality of the evidence was rated as very low for both outcome measures. CONCLUSION: Osteopathy and chiropractic treatment failed to reduce the crying time and increase sleeping time in babies with infantile colic, compared with no additional intervention.
Asunto(s)
Cólico , Terapias Complementarias , Lactante , Humanos , Cólico/terapia , Evaluación de Resultado en la Atención de Salud , Factores de Tiempo , LlantoRESUMEN
OBJECTIVES: Evaluation of safety, efficacy, and feasibility of emergency extracorporeal shockwave lithotripsy (eESWL) in combating obstructing stones with colic on emergency basis. MATERIALS AND METHODS: From November 2019 to November 2021, 102 subjects underwent emergency ESWL for obstructing ureteric and renal stones with colic within 24 h of presentation. RESULTS: Patients in this study belonged to age group of 18-67 years with mean being 39 years consisting of 85 males and 22 females (M:F = 85:22). Mean stone dimensions were 8.26 mm in length and 7.65 mm in width. A total of 42 patients had their stone in kidney or upper ureter while 24 patients had stone in mid ureter and remaining patients (n = 36) had stone in lower ureter. About 65 patients had their stone completely cleared after single ESWL session while 20 patients required multiple sessions to achieve complete clearance. Of these 17 patients (16.67%) were not rendered stone free even after three sessions and had to undergo ureteroscopic lithotripsy (URSL). Overall Stone Free Rate (SFR) was 83.33%. For stone attenuation of ⩽900 HU, SFR was 97.18% while for >900 HU it was only 51.61%. CONCLUSION: eESWL is safe, feasible, and efficacious noninvasive alternative for definitive management of obstructing ureteral and renal stones with colic as far as stone clearance and rapid and definitive pain relief are concerned and that too with very minimal morbidity without the need for admission and hence can reduce the prolonged waiting period for endoscopic stone surgery in any high-volume tertiary care hospital. Length, width, and attenuation of stone were found to be the main factors dictating the success of eESWL.
Asunto(s)
Cólico , Cálculos Renales , Litotricia , Uréter , Cálculos Ureterales , Masculino , Femenino , Humanos , Adolescente , Adulto Joven , Adulto , Persona de Mediana Edad , Anciano , Cálculos Ureterales/complicaciones , Cálculos Ureterales/terapia , Cólico/etiología , Cólico/terapia , Estudios de Factibilidad , Cálculos Renales/complicaciones , Cálculos Renales/terapia , Litotricia/métodos , Morbilidad , Resultado del TratamientoRESUMEN
Resumo Objetivo analisar o uso do aplicativo WhatsApp®, enquanto ferramenta tecnológica, para auxiliar as mães no acompanhamento pós-alta do bebê prematuro. Método estudo de abordagem qualitativa realizado com 18 mães de bebês prematuros que haviam sido internados nas unidades neonatais de um hospital universitário no interior de São Paulo. Os dados foram coletados no período de julho a novembro de 2021 por meio de mensagens deixadas em um grupo de WhatsApp® destinado ao acompanhamento pós-alta dos pré-termo. As mensagens foram analisadas a partir da Análise de Conteúdo Temática. Resultados o grupo de WhatsApp® teve boa aceitação e adesão por parte das mães, que puderam compartilhar suas experiências, seus conhecimentos e sentimentos. Os principais temas levantados foram: Aleitamento materno ao bebê prematuro; Manejo da cólica infantil; Cuidados básicos ao prematuro no domicílio; Vivências na internação do prematuro; Desafios enfrentados no domicílio; Percepção das mães sobre o grupo de WhatsApp®. Conclusão e implicações para a prática as mães demonstraram inseguranças e dúvidas sobre os cuidados básicos com o prematuro em domicílio. A estratégia de utilizar o aplicativo WhatsApp® no acompanhamento em saúde do bebê prematuro apresentou resultados satisfatórios, favorecendo a continuidade do cuidado e o apoio às mães.
Resumen Objetivo analizar el uso de la aplicación WhatsApp®, como herramienta tecnológica, para asistir a las madres en el seguimiento post-alta del bebé prematuro. Método estudio de abordaje cualitativo realizado con 18 madres de prematuros internados en las unidades neonatales de un hospital universitario del interior de São Paulo. Los datos fueron recolectados de julio a noviembre de 2021 a través de mensajes dejados en un grupo de WhatsApp® destinado al seguimiento post-alta de prematuros. Los mensajes fueron analizados a partir del Análisis de Contenido Temático. Resultados el grupo de WhatsApp® fue bien aceptado y adherido por las madres, que pudieron compartir sus experiencias, sus conocimientos y sentimientos. Los principales temas abordados fueron: Lactancia materna del prematuro; Manejo del cólico infantil; Cuidados básicos para bebés prematuros en el hogar; Experiencias en la hospitalización de prematuros; Desafíos enfrentados en el hogar; Percepción de las madres sobre el grupo de WhatsApp®. Conclusión e implicaciones para la práctica las madres mostraron inseguridades y dudas sobre los cuidados básicos del prematuro en el hogar. La estrategia de uso de la aplicación WhatsApp® en el seguimiento de la salud de los bebés prematuros mostró resultados satisfactorios, favoreciendo la continuidad de la atención y el apoyo a las madres.
Abstract Objective to analyze the use of the WhatsApp® application, as a technological tool, to help mothers in the post-discharge follow-up of their premature infant. Method a qualitative study conducted with 18 mothers of preterm infants who had been admitted to the neonatal units of a university hospital in the interior of São Paulo. Data were collected from July to November 2021 through messages left in a WhatsApp® group for the post-discharge follow-up of preterm infants. The messages were analyzed using Thematic Content Analysis. Results the WhatsApp® group had good acceptance and adhesion by the mothers, who were able to share their experiences, knowledge, and feelings. The main topics raised were: Breastfeeding the premature baby; Management of infant colic; Basic care of the premature baby at home; Experiences in the hospitalization of the premature baby; Challenges faced at home; Mothers' perception of the WhatsApp® group. Conclusion and implications for the practice the mothers showed insecurities and doubts about the basic care of the premature baby at home. The strategy of using the WhatsApp® application in the health monitoring of premature babies showed satisfactory results, favoring the continuity of care and support to mothers.
Asunto(s)
Humanos , Masculino , Femenino , Recién Nacido , Lactante , Alta del Paciente , Recien Nacido Prematuro , Enfermería Neonatal , Continuidad de la Atención al Paciente , Aplicaciones Móviles , Atención de Enfermería , Cólico/terapia , Investigación Cualitativa , Nutrición del Lactante , Tés de HierbasRESUMEN
BACKGROUND: Given the possible effect of maternal anxiety on the severity of colic pain in infants, this study aimed to investigate the effects of behavioral therapy counseling on infantile colic (primary outcome), maternal anxiety, and mother-infant attachment (secondary outcomes) in anxious mothers with colicky infants. METHOD: This randomized controlled clinical trial was conducted on 46 anxious mothers of 2-6-weeks-old exclusively breastfed colicky infants who had a score of 112 and above according to the Postpartum Specific Anxiety Scale (PSAS), reffered to the pediatric clinics of Al-Zahra, Taleghani and Children Hospitals of Tabriz, Iran. The participants were randomly assigned to the intervention (n = 23) and control (n = 23) groups using randomized block design. Mothers in the intervention group attended 8 systematic desensitization counseling sessions (2-3 sessions per week). Those in the control group received routine care. The researcher completed the Postpartum Specific Anxiety Scale (PSAS), Mother-Infant Attachment Questionnaire (MIAQ), and Infant Colic Scale (ICS) by interviewing the participants before and two weeks after the intervention. RESULTS: There was no significant difference between the intervention and control groups in the socio-demographic profile of participants. After the intervention, the mean postpartum anxiety score of women in the intervention group was significantly lower than that of those in the control group (Mean Difference (MD) = 22.5, 95% Confidence Interval (CI) = 2.3 to 42.7; p = 0.029). The mean infant colic score of the infants of mothers in the intervention group was insignificantly lower than that of those in the control group (MD = -2.9, 95% CI = -8.3 to 2.4; p = 0.271). In addition, no significant difference was observed between the two groups in terms of their mean mother-infant attachment scores (MD = -0.04, 95% CI = -3.1 to 0.3; p = 0.976). CONCLUSION: Behavioral therapy counseling effectively reduced postpartum anxiety in women with colicky infants; however, this reduction did not lead to a significant decrease in the infants' colic pain. Therefore, health care providers are recommended to use this counseling method in combination with other effective counseling approaches to promote mental health of these mothers. TRIAL REGISTRATION: IRCT Registration Number: IRCT20111219008459N14, registered on 08/10/2020. https://irct.ir/user/trial/45949/view.
Asunto(s)
Cólico , Lactante , Niño , Femenino , Humanos , Cólico/terapia , Cólico/psicología , Consejo , Madres/psicología , Dolor Abdominal , Terapia ConductistaRESUMEN
OBJECTIVE: To evaluate the number of craniosacral therapy sessions that can be helpful to obtain a resolution of the symptoms of infantile colic and to observe if there are any differences in the evolution obtained by the groups that received a different number of Craniosacral Therapy sessions at 24 days of treatment, compared with the control group which did not received any treatment. METHODS: Fifty-eight infants with colic were randomized into two groups of which 29 babies in the control group received no treatment and those in the experimental group received 1-3 sessions of craniosacral therapy (CST) until symptoms were resolved. Evaluations were performed until day 24 of the study. In this study crying hours served as primary outcome. The secondary outcome were the hours of sleep and the severity, measured by an Infantile Colic Severity Questionnaire (ICSQ). RESULTS: Significant statistical differences were observed in favor of experimental group compared to the control group on day 24 in crying hours (mean difference = 2.94, at 95 %CI = 2.30-3.58; p < 0.001) primary outcome, and also in hours of sleep (mean difference = 2.80; at 95 %CI = - 3.85 to - 1.73; p < 0.001) and colic severity (mean difference = 17.24; at 95 %CI = 14.42-20.05; p < 0.001) secondary outcomes. Also, the differences between the groups ≤ 2 CST sessions (n = 19), 3 CST sessions (n = 10) and control (n = 25) were statistically significant on day 24 of the treatment for crying, sleep and colic severity outcomes (p < 0.001). CONCLUSION: Babies with infantile colic may obtain a complete resolution of symptoms on day 24 by receiving 2 or 3 CST sessions compared to the control group, which did not receive any treatment.